Previously, we demonstrated that TIMP-1 interactions with CD63 and subsequent activation of intracellular signaling programs do not require its MMP inhibitory domain2,3,15, indicating that TIMP-1’s opposite effects on tumor progression are mediated by two distinct functional domains. The gene discussed is TIMP1; the disease is neoplasm.